Does OSIMERTINIB Cause Cardiomyopathy? 81 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Cardiomyopathy have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.3% of all adverse event reports for OSIMERTINIB.
81
Reports of Cardiomyopathy with OSIMERTINIB
0.3%
of all OSIMERTINIB reports
9
Deaths
39
Hospitalizations
How Dangerous Is Cardiomyopathy From OSIMERTINIB?
Of the 81 reports, 9 (11.1%) resulted in death, 39 (48.1%) required hospitalization, and 6 (7.4%) were considered life-threatening.
Is Cardiomyopathy Listed in the Official Label?
Yes, Cardiomyopathy is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Cardiomyopathy?
DOXORUBICIN (820)
CYCLOPHOSPHAMIDE (581)
SACUBITRIL\VALSARTAN (444)
CLOZAPINE (404)
PREDNISONE (379)
RITUXIMAB (379)
ROSIGLITAZONE (374)
VINCRISTINE (326)
TRASTUZUMAB (292)
HYDROXYCHLOROQUINE (231)
Which OSIMERTINIB Alternatives Have Lower Cardiomyopathy Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN